These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32362269)

  • 1. The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review.
    Bornemann J
    J Psychoactive Drugs; 2020; 52(4):300-308. PubMed ID: 32362269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.
    Anderson T; Petranker R; Rosenbaum D; Weissman CR; Dinh-Williams LA; Hui K; Hapke E; Farb NAS
    Psychopharmacology (Berl); 2019 Feb; 236(2):731-740. PubMed ID: 30604183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelic microdosing benefits and challenges: an empirical codebook.
    Anderson T; Petranker R; Christopher A; Rosenbaum D; Weissman C; Dinh-Williams LA; Hui K; Hapke E
    Harm Reduct J; 2019 Jul; 16(1):43. PubMed ID: 31288862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting.
    Prochazkova L; Lippelt DP; Colzato LS; Kuchar M; Sjoerds Z; Hommel B
    Psychopharmacology (Berl); 2018 Dec; 235(12):3401-3413. PubMed ID: 30357434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
    Rosenbaum D; Weissman C; Anderson T; Petranker R; Dinh-Williams LA; Hui K; Hapke E
    J Psychopharmacol; 2020 Jun; 34(6):612-622. PubMed ID: 32108529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.
    Polito V; Liknaitzky P
    Neurosci Biobehav Rev; 2022 Aug; 139():104706. PubMed ID: 35609684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelic Microdosing: Prevalence and Subjective Effects.
    Cameron LP; Nazarian A; Olson DE
    J Psychoactive Drugs; 2020; 52(2):113-122. PubMed ID: 31973684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.
    Lo DF; Zia H; Rajkumar P; Thakur A; O'Donnell H
    Prim Care Companion CNS Disord; 2024 Jan; 26(1):. PubMed ID: 38228068
    [No Abstract]   [Full Text] [Related]  

  • 11. The costs and benefits of psychedelics on cognition and mood.
    Sayalı C; Barrett FS
    Neuron; 2023 Mar; 111(5):614-630. PubMed ID: 36681076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powerful substances in tiny amounts: An interview study of psychedelic microdosing.
    Johnstad PG
    Nordisk Alkohol Nark; 2018 Feb; 35(1):39-51. PubMed ID: 32934512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.
    Kuypers KP; Ng L; Erritzoe D; Knudsen GM; Nichols CD; Nichols DE; Pani L; Soula A; Nutt D
    J Psychopharmacol; 2019 Sep; 33(9):1039-1057. PubMed ID: 31303095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.
    Murphy RJ; Sumner R; Evans W; Ponton R; Ram S; Godfrey K; Forsyth A; Cavadino A; Krishnamurthy Naga V; Smith T; Hoeh NR; Menkes DB; Muthukumaraswamy S
    Biol Psychiatry; 2023 Sep; 94(6):511-521. PubMed ID: 36997080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdosing with classical psychedelics: Research trajectories and practical considerations.
    Wong A; Raz A
    Transcult Psychiatry; 2022 Oct; 59(5):675-690. PubMed ID: 36317302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.
    Rootman JM; Kryskow P; Harvey K; Stamets P; Santos-Brault E; Kuypers KPC; Polito V; Bourzat F; Walsh Z
    Sci Rep; 2021 Nov; 11(1):22479. PubMed ID: 34795334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.
    Kaypak AC; Raz A
    Transcult Psychiatry; 2022 Oct; 59(5):665-674. PubMed ID: 36031848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.
    Hutten NRPW; Mason NL; Dolder PC; Kuypers KPC
    Front Psychiatry; 2019; 10():672. PubMed ID: 31572246
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychedelic Microdosing: A Subreddit Analysis.
    Lea T; Amada N; Jungaberle H
    J Psychoactive Drugs; 2020; 52(2):101-112. PubMed ID: 31648596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State Cannabis and Psychedelic Legislation and Microdosing Interest in the US.
    Yang KH; Satybaldiyeva N; Allen MR; Ayers JW; Leas EC
    JAMA Health Forum; 2024 Jun; 5(6):e241653. PubMed ID: 38941086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.